Position in ABEO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,957,947
+$1,579,737 QoQ
Shares Held
1,329,899
+60.1% QoQ
Ownership
2.33%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 62%
Shared 38%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Propel Bio Management, LLC holds $135,066,196 across 34 Biotechnology names. ABEO ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMUX |
Immunic, Inc.
|
2,344,779 | $26,027,046 | |
| 2 | ACHV |
Achieve Life Sciences, Inc.
|
3,786,425 | $11,132,089 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
841,272 | $9,346,531 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
147,828 | $5,958,946 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
This page
|
1,329,899 | $5,957,947 | |
| 6 | VOR |
Vor Biopharma Inc.
|
314,543 | $5,611,447 | |
| 7 | KYTX |
Kyverna Therapeutics, Inc.
|
644,421 | $5,561,353 | |
| 8 | MIST |
Milestone Pharmaceuticals Inc.
|
4,118,321 | $4,900,801 |
All Filings in ABEO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,957,947 | 1,329,899 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,378,210 | 830,780 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,142,836 | 974,022 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,532,444 | 974,022 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,970,344 | 624,022 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,475,802 | 624,022 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,943,819 | 624,022 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,291,706 | 1,248,044 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||